Navigation Links
Wyeth in Medical News

Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Aug. 4 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), issued a statement in response to the Food and Drug Administration (FDA) announcement regarding the results of a safety rev...

Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project

BALTIMORE, June 8 /PRNewswire/ -- Metastorm, a leading provider of Business Process Management (BPM), Business Process Analysis (BPA), and Enterprise Architecture (EA) software for aligning strategy with execution, today announced that CIO Magazine has named Metastorm customer Wyeth Pharmaceutical...

DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza

Two timely sessions at the DIA 45th Annual Meeting reflect the state of today's global biopharmaceutical environment. Horsham, PA, USA (Vocus) June 5, 2009 -- The Drug Information Association (DIA) 45th Annual Meeting is the biopharmaceutical industry's largest an...

Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB

CAMBRIDGE, Mass., April 28 /PRNewswire/ -- Gene Network Sciences, Inc. today announced that it named Dr. Robert Ruffolo, former President of Wyeth Research & Development and a leader in pharmaceutical research to its Scientific Advisory Board. Dr. Ruffolo retired as President of Wyeth Re...

DRI - the Voice of the Defense Bar Responds to Supreme Court Ruling in Wyeth v. Levine

Prominent Legal Organization Optimistic About Ongoing Role for Federal Preemption in Future Liability Cases CHICAGO, March 5 /PRNewswire/ -- DRI - the Voice of the Defense Bar has responded to the decision of the Supreme Court of the United States in Wyeth v. Levine , an important recent ...

NJLRA Statement on Today's U.S. Supreme Court's Decision in Wyeth v. Levine

TRENTON, N.J., March 4 /PRNewswire-USNewswire/ -- The following statement in response to today's U.S. Supreme Court decision is from Marcus Rayner, executive director of the New Jersey Lawsuit Reform Alliance. "We are extremely disappointed in today's Supreme Court decision, which is certain ...

NCC and Wyeth Donation to Assist Cancer Patients in Latin America

LIMA, Peru, Jan. 14 /PRNewswire/ -- The National Cancer Coalition (NCC) and Wyeth Pharmaceuticals (Wyeth) are pleased to announce a pilot program to assist cancer patients in Latin America with donations of Wyeth's cancer-related medicines Mylotarg(TM) (gemtuzumab ozogamicin for injection) and Neu...

SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth Pharmaceuticals

Global pharmaceuticalsleader selects software formultistage inventoryplanning and optimization PITTSBURGH, Dec. 17 /PRNewswire/ -- SmartOps Corporation, the leading provider of enterprise-class supply chain optimization solutions, announced that its Enterprise Inventory Optimization (EIO...

The Senior Citizens League's Comments on U.S. Supreme Court Case Wyeth v. Levine

Oral Argument Scheduled for Monday, November 3, 2008 ALEXANDRIA, Va., Oct. 30 /PRNewswire-USNewswire/ -- On August 14, 2008, The Senior Citizens League (TSCL) filed an amicus brief in support of a courageous Vermont woman's fight to preserve her common law right to damages for the amputation...

Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region

CHICAGO, Oct. 1 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS ) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), have signed a development and commercialization agreement for cethromycin in the Asia Pacific region excluding Japan. Cethromycin is a ...
Wyeth in Medical Technology

Adlyfe Strikes Translational Medicine Partnership With Wyeth Pharmaceuticals for Alzheimer's Biomarker Assay

ROCKVILLE, Md., Feb. 25 /PRNewswire-USNewswire/ -- Adlyfe, a private company developing novel biomarkers and diagnostic tests for amyloid diseases, announced today that it has signed an agreement with Wyeth Pharmaceuticals, a division of Wyeth, to develop biomarker assays designed to measure level...

Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration

SEATTLE, June 19 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN ) today announced that Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), has exercised its option under the terms of its collaboration agreement with Trubion to extend the research period for an addi...

Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)

ATLANTA, Dec. 11 /PRNewswire-USNewswire/ -- The Arthritis Foundation, the leading health organization addressing the needs of 46 million Americans living with arthritis, today announced that Amgen and Wyeth Pharmaceuticals, co-marketers of Enbrel (R) (etanercept), will be the national presenti...

Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia

MARIETTA, Ga., Aug. 10 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announced today the receipt of an action letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for bifeprunox, an at...

Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness

TARRYTOWN, N.Y. & MADISON, N.J.--(BUSINESS WIRE)--Jun 28, 2007 - Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced positive results from a three-month open-label extension study of subcutaneous methylnaltrexone for the tre...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

...EVILLE, Pa., July 27 /PRNewswire-FirstCall/ -- wyeth Pharmaceuticals, a division of wyeth (NYSE: WYE ), announced the publication in Fert...apeutic use was <1%. BZA/CE is being studied by wyeth Pharmaceuticals for the treatment of moderate-to-s...

Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)

...087 for autoimmune and inflammatory diseases, developed under the Company's wyeth collaboration. Trubion's product pipeline also includes Trubion's proprieta...o, risks associated with the clinical advancement of TRU-016, the Company's wyeth collaboration, including Wyeth's control over development timelines, the ri...

New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer

...OLLEGEVILLE, Pa., May 29 /PRNewswire-FirstCall/ -- wyeth Pharmaceuticals, a division of wyeth (NYSE: WYE ), today announced preliminary data f... says Gary L. Stiles, M.D., Chief Medical Officer, wyeth Pharmaceuticals. "These additional data build upo...

Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting

...087 for autoimmune and inflammatory diseases, developed under the company's wyeth collaboration. Trubion's product pipeline also includes Trubion's proprieta...o, risks associated with the clinical advancement of TRU-016, the company's wyeth collaboration, including Wyeth's control over development timelines, the ri...

Another LNA-based RNA Inhibitor Enters Clinical Trials

...compounds in clinical development and a full pipeline in late preclinical development. Current partners are Enzon Pharmaceuticals, GlaxoSmithKline and wyeth Pharmaceuticals. Santaris Pharma has since its inception raised nearly $100 million through private financing and up front payments. About Enzo...
Wyeth in Medical Dictionary

Subcutaneous

...ubcutaneous Infusion of Opiates at End-of-Life. Ann. Pharmacother. ... wyeth Pharmaceuticals, a division of wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. ... RELISTOR subcutaneous...
Wyeth in Biological News

Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design

HAYWARD, Calif., Nov. 27 /PRNewswire/ -- Singulex Inc. today announced that it is collaborating with researchers at Wyeth Research to develop immunoassays on the company's Erenna(TM) system. Singulex has installed the Erenna system at Wyeth as part of its Erenna Technology Access Program (ETAP...

CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda

...r, Biomarker Lab, Clinical Translational Medicine, wyeth Pharmaceuticals C. Thomas Caskey, M.D., F.A...dent & Head, Discovery Translational Medicine, wyeth Research Paul J. Fielder, Ph.D., Senio...amp; Outsourcing, Clinical Translational Medicine, wyeth Research Xinkang Wang, Ph.D., Head, Imaging...

Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award

...r many scholarly journals, including the IADR's Journal of Dental Research , Gerontology , and the New England Journal of Medicine . Supported by wyeth Consumer Healthcare, the Pharmacology/Therapeutics/Toxicology Research Award is one of the 16 IADR Distinguished Scientist Awards and is one of the hi...

Birth control has long-term effect on hormone exposure

...ffects on many aspects of female health. Half of the monkeys were given a birth control treatment of triphasic estrogen and progestin, marketed by wyeth Pharmaceuticals as TriphasilTM, for 26 months. At the end of the premenopausal phase of the study, the animals underwent surgery to have their ovaries...

Breast cancer treatment resistance linked to signaling pathway

...us to overcome some aspects of drug resistance in the clinic," said Christina M. Coughlin, M.D., Ph.D., medical director and global medical monitor at wyeth Pharmaceuticals, who lead this research in Wyeth's Department of Discovery Translational Medicine. The identification of genetically altered pathw...

Tips from the Journals of the American Society for Microbiology

...ed for efficacy in mice challenged with smallpox. wyeth IL-15 included a strain of the vaccinia virus deri...dered as a substitute for the Dryvax vaccine. The wyeth IL-15 vaccine resulted in a 1,000-fold reduction i...une responses. Additionally, mice vaccinated with wyeth IL-15 fully survived a lethal intranasal challenge...

The secret lives of sea slugs

...in controls behavior, a field known as neuroethology. Biologists Russell wyeth and Dennis Willows, of University of Washington's Friday Harbor Laboratorie...you have a starting point to see how the brain is actually controlling it," wyeth says. ...

Mouse study: New muscle-building agent beats all previous ones

... The Johns Hopkins scientists who first created "mighty mice" have developed, with pharmaceutical company wyeth and the biotechnology firm MetaMorphix, an agent that's more effective at increasing muscle mass in mice than a related potential treatment for muscul...

Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses

..." Consortium funding for expO’s launch comes from six international pharmaceutical firms. Major sponsors are Bristol-Myers Squibb, GlaxoSmithKline, wyeth and IBM. Other sponsors are Pfizer, Aventis, Johnson & Johnson, Flinn Foundation, ILEX Oncology, and Genomics Collaborative Inc. Research suppo...
Wyeth in Biological Technology

Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration

SEATTLE, June 22 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ) today announced that Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), has exercised its option under the terms of its collaboration agreement with Trubion to extend the research period for an addit...

Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.

NEW YORK, May 19 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease (AD), announced today that it has entered into...

Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies

SOUTH SAN FRANCISCO, Calif., Dec. 6 /PRNewswire/ -- Raven biotechnologies, inc., a privately held company focused on the development of monoclonal antibody therapeutics (MAbs) for cancer, today announced that Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), has exercised an option to ...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...atments for CAP and their interest in seeing the Company pursue further development. We continue to receive strong support from our commercial partner wyeth and intend to work in close collaboration with them as we implement our clinical program. We believe that Restanza has significant therapeutic and com...

Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call

... pipeline includes CD20-directed SMIP therapeutics such as TRU-015 and SBI-087 for autoimmune and inflammatory diseases, developed under the Company's wyeth collaboration. Trubion's product pipeline also includes Trubion's proprietary product candidate, TRU-016, a novel CD37-targeted therapy for the treatm...

Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting

... MADISON, N.J., July 20 /PRNewswire-FirstCall/ -- wyeth (NYSE: WYE ) today announced that its stockholde...harmaceutical and vaccine products in 2008, making wyeth the fourth largest biotechnology company in the wo...sing." At the closing of the transaction, wyeth stockholders will be entitled to receive $33 in ca...

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

... three partners, covering up to 22 novel LNA-based RNA therapeutics: wyeth Pharmaceuticals (December 2008) By the end of 2008 Santaris Pharma e...llaboration Santaris Pharma will design and generate the drug compounds and wyeth will be responsible for all preclinical- and clinical development as well a...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

...tCall/ -- Elan Corporation, plc (NYSE: ELN ) and wyeth (NYSE: WYE ) presented information this week at ...al. Editors Note: The following Elan and wyeth abstracts were also presented at ICAD: ... hallucinations. About the Elan and wyeth Collaboration The Alzheimer's Immunotherapy ...

World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

...gies Corporation, Nanosphere Inc., Nektar Therapeutics, Novavax Inc., Oxonica Plc, Par Pharmaceutical Companies Inc., Starpharma Holdings Limited, and wyeth Pharmaceuticals Inc., among others. The report titled "Nanomedicine: A Global Strategic Business Report" announced by Global Industry An...

Virtify, Inc. Delivers Industry's First Enterprise Content Compliance Software Suite for Life Sciences Companies

...y enabling content structure and re-use across the many tasks required for engineering validation and other activities, Virtify enables companies like wyeth to streamline these efforts, reduce costs and increase operating performance through the product life cycle." The Industry's First Collaborative...
Other Tags
(Date:12/20/2014)... DePuy Pinnacle hip lawsuits ( ... the artificial hip system was defectively designed continue ... Bernstein Liebhard LLP reports. According to an Order ... on December 2nd, counsel in 10 DePuy Pinnacle ... on November 19, 2014, with depositions to conclude ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 The Doctor’s Office ... for the better part of a decade. They’ve treated ... a better, faster healthcare alternative to the Paramus ... announce three new additions to their staff of top-notch board ... Jill Zeiger MD. These new doctors will work ...
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... Entertainment has caused quite a stir, not only in Hollywood, ... Times on December 18th , the ripples of that attack ... level executives’ very jobs at risk. But they are ... email correspondences exposed could be in for some embarrassing times ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 The Twin ... protection education event in the nation! Over 250 financial ... the minute information on the industry, get motivated to ... of real people facing and overcoming the challenges of ... all across the nation came together to attend The ...
(Date:12/19/2014)... It’s very easy to become overwhelmed with the holidays ... the wayside until Christmas and the New Year are over. ... that burning desire to just escape it all and get ... Telluride with a no-fuss, affordable package. Montrose Days Inn will ... and ensure that all accommodations are met. Plus, everyone has ...
Breaking Medicine News(10 mins):Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2
(Date:12/11/2014)... Dec. 10, 2014  That blood pressure plays a role ... Hypertension – the medical term for high blood pressure – ... and the inflatable cuff that,s used in measuring blood pressure ... there,s nothing new about hypertension, its triggers and its effects. ... the condition and the best ways to treat it. ...
(Date:12/10/2014)... , Dec. 8, 2014 You,ve been here ... account but can,t remember your password, site key or the ... was your first grade teacher? Today, ... the app that will finally put an end to ... 1U TM . 1U leverages a user,s smartphone ...
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced ... School of Medicine. Funding for this $50 million capital ... will be publicly launched next summer. ... former 60 series R.J. Reynolds Tobacco Company complex, adjacent ... begin immediately with plans to be ready to welcome ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
Other Contents